Clinical Trials for AnHeart Therapeutics

Explore 6 clinical trials worldwide

Showing 1-6 of 6 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: AnHeart Therapeutics

Clinical Trials (6)

NCT06564324
A Phase III Study Comparing Taletrectinib With Standard Therapy in ROS1 Positive Locally Advanced or Metastatic Non-small Cell Lung Cancer Patients
PHASE3Recruiting
138 participants
Started: Nov 27, 2024 · Completed: Sep 30, 2030
1 condition2 sponsors11 locations
NCT05303519
Safusidenib Phase 2 Study in IDH1 Mutant Glioma
PHASE2Recruiting
125 participants
Started: Jun 5, 2023 · Completed: Mar 1, 2028
5 conditions2 sponsors31 locations
NCT05577416
A Study of AB-218 in Patients With IDH1 Mutated Low Grade Glioma
EARLY_PHASE1Recruiting
15 participants
Started: Oct 11, 2022 · Completed: Dec 1, 2025
1 condition3 sponsors1 location
NCT04617054
Basket Study of AB-106 for the Treatment of Patients With Solid Tumors With NTRK Fusion Gene
PHASE2Recruiting
40 participants
Started: Jun 1, 2021 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT04395677
A Study of AB-106 in Subjects With Advanced NSCLC Harboring ROS1 Fusion Gene
PHASE2Active, not recruiting
173 participants
Started: Jul 7, 2020 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT04151342
CAnadian CAncers With Rare Molecular Alterations (CARMA) - Basket Real-world Observational Study (BROS)
N/ARecruiting
1,000 participants
Started: Jan 17, 2020 · Completed: Dec 31, 2025
10 conditions8 sponsors27 locations